Ignite Creation Date:
2024-05-05 @ 4:41 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00299494
Status:
COMPLETED
Last Update Posted:
2018-03-08
First Post:
2006-03-02
Brief Title:
Study Evaluating Inotuzumab Ozogamicin CMC-544 Administered In Combination With Rituximab In Subjects With Non-Hodgkins Lymphoma NHL
Sponsor:
Pfizer
Organization:
Pfizer
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-05-04
Start Date Type:
ACTUAL
Primary Completion Date:
2014-05-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-06-02
Completion Date Type:
ACTUAL
First Submit Date:
2006-03-02
First Submit QC Date:
March 2 2006
Study First Post Date:
2006-03-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2018-03-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2015-07-21
Disp First Submit QC Date:
July 21 2015
Disp First Post Date:
2015-08-11
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2018-02-06
Last Update Post Date:
2018-03-08
Last Update Post Date Type:
ACTUAL